EPO dismisses Dexcom’s appeal over revoked diabetes patent
MLex Summary: The European Patent Office’s Board of Appeal has dismissed Dexcom's appeal concerning the revocation of its EP 3,782,539, related to alarm systems for diabetes monitoring. Dexcom, which lost the...To view the full article, register now.
Already a subscriber? Click here to view full article